Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab

著者: Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, Elliott D. Crouser, Greg S. Martin, Timothy E. Albertson, Raquel R. Bartz, Scott C. Brakenridge, Matthew J. Delano, Pauline K. Park, Michael W. Donnino, Mark Tidswell, Florian Mayr, Derek C. Angus, Craig M. Coopersmith, Lyle L. Moldawer, Ian M. Catlett, Ihab Girgis, June Ye, Dennis M. Grasela - Intensive Care Medicine 2019 被引用: 194